San Francisco, CA, United States of America

Joanne Bl Tan

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Arcus Biosciences, Inc.. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joanne Bl Tan: Innovator in Oncogene-Driven Cancer Treatment

Introduction

Joanne Bl Tan is a prominent inventor based in San Francisco, CA, specializing in innovative treatments for oncogene-driven cancers. With a focus on advancing cancer therapies, she has made significant contributions to the field of oncology.

Latest Patents

Joanne holds a patent for her groundbreaking work titled "Treatment of oncogene-driven cancers." This patent outlines methods for treating subjects identified as having oncogene-driven cancer by administering agents that target the extracellular production of adenosine and/or antagonize the activation of adenosine receptors. Her innovative approach aims to improve treatment outcomes for patients suffering from these challenging cancers. She has 1 patent to her name.

Career Highlights

Joanne is currently employed at Arcus Biosciences, Inc., where she continues to develop and refine her cancer treatment methodologies. Her work at Arcus has positioned her as a key player in the fight against oncogene-driven cancers, contributing to the company's mission of advancing cancer therapies.

Collaborations

Joanne collaborates with talented professionals in her field, including Akshata R Udyavar and Stephen W Young. These collaborations enhance her research and development efforts, fostering innovation in cancer treatment.

Conclusion

Joanne Bl Tan is a dedicated inventor whose work in oncogene-driven cancer treatment is making a significant impact in the medical field. Her innovative approaches and collaborations are paving the way for advancements in cancer therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…